Study of immunological response in Clinical pharmacological test of BK-SE36/CpG

Study of immunological response in Clinical pharmacological test of BK-SE36/CpG - Study of immunological response to BK-SE36/CpG

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012980

Enrollment

Registered

2014-01-30

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: who consent to participate in this clinical study, of subjects of vaccine trials in MRT(medical center for translational and clinical research Osaka university hospital)

Exclusion criteria

Exclusion criteria: Not obtained the agreement

Design outcomes

Primary

Measure	Time frame
Antibody function is analyzed by immunoglobulin subtype assay , antibody dependent cell mediated cytotoxicity assay. For all of the human microRNA that are registered in miRBase (microRNA Datebase), microRNA expression in sample is analized comprehensively by methods such as microRNA chip, a next-generation sequencer.	—

Countries

Japan

Contacts

Public ContactKen Ishii

National Institutes of Biomedical Innovation,Health and Nutrition Laboratory of Adjuvant Innovation

kenishii@biken.osaka-u.ac.jp072-641-8043

Outcome results